Life Time Group Holdings, Inc. (LTH) closed the last trading session at $27.54, gaining 7.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $40.36 indicates a 46.6% upside potential.The average comprises 11 short-term price targets ranging from a low of $33.00 to a high of $48.00, with a standard deviation of $4.59. While the lowest estimate indicates an increase of 19.8% from the ...

Abacus Life, Inc. (ABL) closed the last trading session at $6.23, gaining 17.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.1 indicates an 110.3% upside potential.The average comprises five short-term price targets ranging from a low of $9.00 to a high of $15.00, with a standard deviation of $2.36. While the lowest estimate indicates an increase of 44.5% from the current pr ...

Core Viewpoint - Marvell Technology Inc (NASDAQ:MRVL) is a significant player in the semiconductor industry, providing essential components for data infrastructure, with a price target of $85 set by Frank Lee from HSBC, indicating potential growth from its current price of $77.45 [1][6] Company Performance - MRVL is currently trading at $77.24, slightly below the price at the time of Lee's announcement, following a recent 5% decline linked to broader market challenges, particularly the waning momentum of Nvidia's post-earnings rally [2] - The stock has found support at the $80 level, maintaining a historically bullish trendline, and has stayed above this level 80% of the time over the past two weeks [3] - MRVL's market capitalization is approximately $66.78 billion, with a trading volume of 16,211,023 shares today, indicating active trading [5] Historical Trends - Historically, similar market conditions have led to MRVL rising 78% of the time one month later, with an average increase of 7.7% [4][6] - Over the past year, MRVL has experienced a high of $127.48 and a low of $47.09, reflecting its volatility in the market [5]

On Holding (ONON) closed the last trading session at $43.3, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $60.68 indicates a 40.1% upside potential.The average comprises 22 short-term price targets ranging from a low of $30.00 to a high of $85.00, with a standard deviation of $10.3. While the lowest estimate indicates a decline of 30.7% from the current price level, ...

With a market cap of around $25 billion, STERIS plc (STE) is a global provider of infection prevention products and services supporting hospitals, healthcare providers, and pharmaceutical manufacturers. Through its Healthcare, Applied Sterilization Technologies, and Life Sciences segments, the company delivers sterilization equipment, contract sterilization services, and specialized consumables that ensure safe, sterile environments. Shares of the Mentor, Ohio-based company have outpaced the broader marke ...

Shares of Jade Biosciences, Inc. (JBIO) have gained 25.9% over the past four weeks to close the last trading session at $12.59, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $19.2 indicates a potential upside of 52.5%.The average comprises five short-term price targets ranging from a low of $14.00 to a high of $28.00, with a standard deviation of $5.36. While the lowest estima ...

Core Viewpoint - Natural Gas Services (NGS) has shown a significant price increase of 13.4% over the past four weeks, with a mean price target of $38.25 indicating a potential upside of 29.3% from the current price of $29.58 [1] Price Targets and Analyst Consensus - The average price target for NGS ranges from a low of $34.00 to a high of $45.00, with a standard deviation of $4.99, suggesting a variability in estimates [2] - The lowest estimate indicates a 14.9% increase, while the highest suggests a 52.1% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts have shown strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has increased, leading to a 9.5% rise in the Zacks Consensus Estimate for the current year [12] - NGS holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Electromed, Inc. (ELMD) shares have increased by 8.4% in the past four weeks, closing at $26.35, with a potential upside of 39.2% based on Wall Street analysts' mean price target of $36.67 [1][4]. Price Targets - The average price target for ELMD ranges from a low of $36.00 to a high of $38.00, with a standard deviation of $1.15, indicating a relatively tight clustering of estimates [2][9]. - The lowest estimate suggests a 36.6% increase from the current price, while the highest estimate indicates a 44.2% upside [2]. Analyst Sentiment - Analysts show strong agreement in revising earnings estimates higher, which historically correlates with positive stock price movements [4][11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 2.9%, with two estimates moving higher and no negative revisions [12]. Zacks Rank - ELMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a solid potential upside [13]. Conclusion on Price Targets - While the consensus price target may not be a reliable predictor of the exact price movement, it does provide a useful directional guide for potential stock performance [14].

Core Viewpoint - Gen Digital (GEN) shows potential for significant upside, with a mean price target of $34.38 indicating a 28.7% increase from its current price of $26.72 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $5.5, suggesting variability in analyst predictions. The lowest estimate is $29.00 (8.5% increase), while the highest is $46.00 (72.2% increase) [2][9]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown growing optimism regarding GEN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions. This correlation between earnings revisions and stock price movements supports the expectation of an upside [11][12]. - Over the past 30 days, the Zacks Consensus Estimate for the current year has increased by 1.3%, with one estimate moving higher and no negative revisions [12]. Zacks Rank and Investment Potential - GEN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]. - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14].

Core Viewpoint - Rapport Therapeutics, Inc. (RAPP) shows significant upside potential with a mean price target of $52.14, indicating a 104.5% increase from the current trading price of $25.5 [1] Price Targets and Analyst Consensus - The average price target consists of seven estimates ranging from a low of $34.00 to a high of $80.00, with a standard deviation of $14.12, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 33.3% increase, while the highest suggests a 213.7% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about RAPP's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.2%, with three estimates moving higher and no negative revisions [12] - RAPP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common tool for investors, they can often mislead and should not be the sole basis for investment decisions [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]